The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions
Abstract
Background There has been tremendous growth in research in pediatric multiple sclerosis (MS) and immune mediated central nervous system demyelinating disorders since operational definitions for these conditions were first proposed in 2007. Further, the International Pediatric Multiple Sclerosis Study Group (IPMSSG), which proposed the criteria, has expanded substantially in membership and in its international scope. Objective The purpose of this review is to revise the 2007 definitions in order to incorporate advances in delineating the clinical and neuroradiologic features of these disorders. Methods Through a consensus process, in which input was sought from the 150 members of the Study Group, criteria were drafted, revised and finalized. Final approval was sought through a web survey. Results Revised criteria are proposed for pediatric acute disseminated encephalomyelitis, pediatric clinically isolated syndrome, pediatric neuromyelitis optica and pediatric MS. These criteria were approved by 93% or more of the 56 Study Group members who responded to the final survey. Conclusions These definitions are proposed for clinical and research purposes. Their utility will depend on the outcomes of their application in prospective research.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although MS typically presents at age 20-50 years, approximately 0.5% of adults with MS have symptom onset at age 60 years or older. 42,43”
From Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria (2018) · cites this paper as [43]
In the citing paper
“In younger children (<12 years) MS may present differently from adolescents and adults; encephalopathy, multifocal neurological deficits (often with prominent brainstem/cerebellar involvement) and seizures are more common.32”
From Diagnosis of multiple sclerosis: progress and challenges (2017) · cites this paper as [32]
In the citing paper
“Up to 5% of people with MS develop their first symptoms in childhood, almost always RRMS. 32”
From Diagnosis of multiple sclerosis: progress and challenges (2017) · cites this paper as [32]
In the citing paper
“The performance of the McDonald 2010 criteria has been tested in children with CIS and the criteria have a similar sensitivity/specificity for the development of MS as in adult populations 35 but should not be applied in the setting of encephalopathy (i.e.ADEM).32”
From Diagnosis of multiple sclerosis: progress and challenges (2017) · cites this paper as [32]
In the citing paper
“ADEM is almost always monophasic; however, an encephalopathic ADEM-like illness can sometimes be the first presentation of MS in both children 32,34 and adults 43 and diagnostic criteria for ADEM remain imperfect.”
From Diagnosis of multiple sclerosis: progress and challenges (2017) · cites this paper as [32]
In the citing paper
“The clinical, imaging and laboratory features of ADEM and MS overlap and diagnostic criteria emphasise the requirement of encephalopathy (altered level of consciousness, behavioural or cognitive change) in making the diagnosis of ADEM (Supplementary Panel 1).32”
From Diagnosis of multiple sclerosis: progress and challenges (2017) · cites this paper as [32]
In the citing paper
“Older children (≥12 years) usually present with clinical features and MRI findings similar to adults with CIS.32,34”
From Diagnosis of multiple sclerosis: progress and challenges (2017) · cites this paper as [32]
Citations
Cites
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802
Self-citationRevised diagnostic criteria for neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,568
Barkhof, F. (1997) · Brain · doi:10.1093/brain/120.11.2059 · Cited by 1,251
Fisniku, L. K., Brex, P. A., Altmann, D. R., Miszkiel, K. A., Benton, C. E., Lanyon, R., Thompson, A. J., & Miller, D. H. (2008) · Brain · doi:10.1093/brain/awm329 · Cited by 897
Consensus definitions proposed for pediatric multiple sclerosis and related disorders
Krupp, L., Banwell, B., & Tenembaum, S. N. (2007) · Neurology · doi:10.1212/01.wnl.0000259422.44235.a8 · Cited by 757
Self-citationAcute disseminated encephalomyelitis
Tenembaum, S. N., Chamoles, N., & Fejerman, N. (2002) · Neurology · doi:10.1212/wnl.59.8.1224 · Cited by 708
Self-citationIncreased Relapse Rate in Pediatric-Onset Compared With Adult-Onset Multiple Sclerosis
Gorman, M., Healy, B. C., Polgar‐Turcsanyi, M., & Chitnis, T. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.505 · Cited by 459
Self-citationEarly onset multiple sclerosis
Бойко, А. Н., Vorobeychik, G., Paty, D. W., Devonshire, V., & Sadovnick, A. D. (2002) · Neurology · doi:10.1212/wnl.59.7.1006 · Cited by 417
Acute Disseminated Encephalomyelitis in Childhood: Epidemiologic, Clinical and Laboratory Features
Leake, J. A. D., Albani, S., Kao, A. S., Senac, M. O., Billman, G. F., Nespeca, M., Paulino, A., Quintela, E. R., Sawyer, M. H., & Bradley, J. S. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000133048.75452.dd · Cited by 411
Course and prognosis in early-onset MS
Simone, I. L., Carrara, D., Tortorella, C., Liguori, M., Lepore, V. L., Pellegrini, F., Bellacosa, A., Ceccarelli, A., Pavone, I., & Livrea, P. (2002) · Neurology · doi:10.1212/01.wnl.0000036907.37650.8e · Cited by 341
Cited by
Sorted by citations
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Thompson, A. J., Banwell, B. L., Barkhof, F., Carroll, W. M., Coetzee, T., Comi, G., Correale, J., Fazekas, F., Filippi, M., Freedman, M. S., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30470-2 · Cited by 8,167
Self-citationInternational consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Wingerchuk, D. M., Banwell, B., Bennett, J. L., Cabre, P., Carroll, W., Chitnis, T., de Seze, J., Fujihara, K., Greenberg, B., Jacob, A., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001729 · Cited by 4,649
Self-citationA clinical approach to diagnosis of autoimmune encephalitis
Graus, F., Titulaer, M. J., Balu, R., Benseler, S. M., Bien, C. G., Cellucci, T., Cortese, I. C. M., Dale, R. C., Gelfand, J. M., Geschwind, M. D., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00401-9 · Cited by 4,580
Self-citationNeurological associations of COVID-19
Ellul, M. A., Benjamin, L., Singh, B., Lant, S., Michael, B. D., Easton, A., Kneen, R., Defres, S., Sejvar, J., & Solomon, T. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30221-0 · Cited by 2,156
Thompson, A. J., Baranzini, S. E., Geurts, J. J. G., Hemmer, B., & Ciccarelli, O. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30481-1 · Cited by 1,979
Banwell, B., Bennett, J. L., Marignier, R., Kim, H. J., Brilot, F., Flanagan, E. P., Ramanathan, S., Waters, P. J., Tenembaum, S. N., Graves, J., et al. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00431-8 · Cited by 1,350
Self-citationClinical presentation and prognosis in MOG-antibody disease: a UK study
Juryńczyk, M., Messina, S., Woodhall, M. R., Raza, N., Everett, R., Roca‐Fernández, A., Tackley, G., Hamid, S. H. M., Sheard, A., Reynolds, G. L., et al. (2017) · Brain · doi:10.1093/brain/awx276 · Cited by 742
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
Montalbán, X., Gold, R., Thompson, A. J., Otero‐Romero, S., Amato, M. P., Chandraratna, D., Clanet, M., Comı, G., Derfuss, T. J., Fazekas, F., et al. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458517751049 · Cited by 739
Self-citationDiagnosis of multiple sclerosis: progress and challenges
Brownlee, W. J., Hardy, T. A., Fazekas, F., & Miller, D. H. (2017) · The Lancet · doi:10.1016/s0140-6736(16)30959-x · Cited by 701
Connelly‐Smith, L. S., Alquist, C. R., Aqui, N. A., Hofmann, J. C., Klingel, R., Onwuemene, O. A., Patriquin, C. J., Pham, H. P., Sanchez, A. P., Schneiderman, J., et al. (2023) · Journal of Clinical Apheresis · doi:10.1002/jca.22043 · Cited by 751
Ramanathan, S., Mohammad, S. S., Tantsis, E. M., Nguyen, T. K., Merheb, V., Fung, V. S. C., White, O. B., Broadley, S., Lechner‐Scott, J., Vucic, S., et al. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-316880 · Cited by 574
Self-citationClinical spectrum and prognostic value of CNS MOG autoimmunity in adults
Cobo‐Calvo, Á., Ruiz, A., Maillart, É., Audoin, B., Zéphir, H., Bourre, B., Ciron, J., Collongues, N., Brassat, D., Cotton, F., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005560 · Cited by 541
Hacohen, Y., Wong, Y. Y. M., Lechner, C., Juryńczyk, M., Wright, S. K., Konuşkan, B., Kalser, J., Poulat, A., Maurey, H., Ganelin‐Cohen, E., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.4601 · Cited by 428
Self-citationChen, J. J.-W., Flanagan, E. P., Jitprapaikulsan, J., Lopez-Chiriboga, A. S., Fryer, J. P., Leavitt, J. A., Weinshenker, B. G., McKeon, A. B., Tillema, J., Lennon, V. A., et al. (2018) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2018.07.020 · Cited by 410
Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome
Pohl, D., Alper, G., Van Haren, K., Kornberg, A. J., Lucchinetti, C. F., Tenembaum, S., & Belman, A. L. (2016) · Neurology · doi:10.1212/wnl.0000000000002825 · Cited by 462
Self-citationNeuromyelitis optica: clinical features, immunopathogenesis and treatment
Jarius, S., Wildemann, B., & Paul, F. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12271 · Cited by 360
Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome
Hennes, E.-M., Baumann, M., Schanda, K., Anlar, B., Bajer-Kornek, B., Blaschek, A., Brantner-Inthaler, S., Diepold, K., Eisenkölbl, A., Gotwald, T., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004312 · Cited by 341
Self-citationArmangué, T., Olivé-Cirera, G., Martínez‐Hernández, E., Sepúlveda, M., Ruiz‐García, R., Muñoz-Batista, M., Ariño, H., González-Álvarez, V., Felipe‐Rucián, A., Martínez-González, M. J., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30488-0 · Cited by 348
Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis
Chitnis, T., Arnold, D. L., Banwell, B., Brück, W., Ghezzi, A., Giovannoni, G., Greenberg, B. M., Krupp, L., Rostasy, K. M., Tardieu, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800149 · Cited by 333
Self-citationBaumann, M., Sahin, K., Lechner, C., Hennes, E. M., Schanda, K., Mader, S., Karenfort, M., Selch, C., Häusler, M., Eisenkölbl, A., et al. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-308346 · Cited by 313
Self-citationHöftberger, R., Sepúlveda, M., Armangué, T., Blanco, Y., Rostasy, K. M., Cobo‐Calvo, Á., Olascoaga, J., Ramió‐Torrentà, L., Reindl, M., Benito‐León, J., et al. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514555785 · Cited by 288
Self-citationThe neurological complications of chikungunya virus: A systematic review
Mehta, R., Gérardin, P., de Brito, C. A. A., Soares, C., Ferreira, M. L. B., & Solomon, T. (2018) · Reviews in Medical Virology · doi:10.1002/rmv.1978 · Cited by 259
Pediatric multiple sclerosis: a review
Alroughani, R., & Boyko, A. (2018) · BMC Neurology · doi:10.1186/s12883-018-1026-3 · Cited by 236
Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children
Hacohen, Y., Absoud, M., Deiva, K., Hemingway, C., Nytrova, P., Woodhall, M., Palace, J., Wassmer, E., Tardieu, M., Vincent, A., et al. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000081 · Cited by 230
Self-citationECTRIMS / EAN guideline on the pharmacological treatment of people with multiple sclerosis
Montalbán, X., Gold, R., Thompson, A. J., Otero‐Romero, S., Amato, M. P., Chandraratna, D., Clanet, M., Comı, G., Derfuss, T. J., Fazekas, F., et al. (2018) · European Journal of Neurology · doi:10.1111/ene.13536 · Cited by 233
Self-citationLindan, C. E., Mankad, K., Ram, D., Kociolek, L. K., Silvera, V. M., Boddaert, N., Stivaros, S. M., Palasis, S., Akhtar, S., Alden, D., et al. (2020) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(20)30362-x · Cited by 214
Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease
Dalmau, J. O., & Graus, F. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00083-2 · Cited by 204
Diagnostic algorithm for relapsing acquired demyelinating syndromes in children
Hacohen, Y., Mankad, K., Chong, W. K., Barkhof, F., Vincent, A., Lim, M., Wassmer, E., Ciccarelli, O., & Hemingway, C. (2017) · Neurology · doi:10.1212/wnl.0000000000004117 · Cited by 190
Self-citationInflammatory demyelinating diseases of the central nervous system
Höftberger, R., & Lassmann, H. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802395-2.00019-5 · Cited by 206
Identifying the Distinct Cognitive Phenotypes in Multiple Sclerosis
Meo, E. D., Portaccio, E., Giorgio, A., Ruano, L., Goretti, B., Niccolai, C., Patti, F., Chisari, C. G., Gallo, P., Grossi, P., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2020.4920 · Cited by 190
Self-citationAnti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort
Ketelslegers, I. A., van Pelt, D., Bryde, S., Neuteboom, R. F., Catsman‐Berrevoets, C. E., Hamann, D., & Hintzen, R. Q. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514566666 · Cited by 180
Self-citationBruijstens, A. L., Lechner, C., Flet‐Berliac, L., Deiva, K., Neuteboom, R. F., Hemingway, C. A., Wassmer, E., Bruijstens, A. L., Wendel, E., Lechner, C., et al. (2020) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2020.10.006 · Cited by 174
Self-citationAntibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton
Dale, R. C., Tantsis, E. M., Merheb, V., Kumaran, R.-Y. A., Sinmaz, N., Pathmanandavel, K., Ramanathan, S., Booth, D. R., Wienholt, L. A., Prelog, K., et al. (2014) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000012 · Cited by 173
Self-citationEvidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS
Gianfrancesco, M. A., Stridh, P., Rhead, B., Shao, X., Xu, E., Graves, J., Chitnis, T., Waldman, A. T., Lotze, T. E., Schreiner, T., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000003849 · Cited by 172
Self-citationJarius, S., Pellkofer, H., Siebert, N., Korporal‐Kuhnke, M., Hümmert, M. W., Ringelstein, M., Rommer, P. S., Ayzenberg, I., Ruprecht, K., Klotz, L., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01824-2 · Cited by 179
Self-citationMariotto, S., Ferrari, S., Monaco, S., Benedetti, M. D., Schanda, K., Alberti, D., Farinazzo, A., Capra, R., Mancinelli, C. R., Rossi, N. D., et al. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8635-4 · Cited by 166
Peschl, P., Schanda, K., Zeka, B., Given, K. S., Böhm, D., Ruprecht, K., Saiz, A., Lutterotti, A., Rostasy, K. M., Höftberger, R., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0984-5 · Cited by 163
Self-citationAtypical inflammatory demyelinating syndromes of the CNS
Hardy, T. A., Reddel, S. W., Barnett, M. H., Palace, J., Lucchinetti, C. F., & Weinshenker, B. G. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30043-6 · Cited by 161
Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease
Cobo‐Calvo, Á., Sepúlveda, M., Rollot, F., Armangué, T., Ruiz, A., Maillart, É., Papeix, C., Audoin, B., Zéphir, H., Biotti, D., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1525-1 · Cited by 160
Ray, S., Abdel‐Mannan, O., Sá, M., Fuller, C., Wood, G. K., Pysden, K., Yoong, M. M., McCullagh, H., Scott, D., McMahon, M., et al. (2021) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(21)00193-0 · Cited by 159
Self-citationWaldman, A. T., Ghezzi, A., Bar‐Or, A., Mikaeloff, Y., Tardieu, M., & Banwell, B. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70093-6 · Cited by 159
Self-citationBaumann, M., Hennes, E.-M., Schanda, K., Karenfort, M., Kornek, B., Seidl, R., Diepold, K., Lauffer, H., Marquardt, I., Strautmanis, J., et al. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516631038 · Cited by 156
Self-citationBruijstens, A. L., Wendel, E., Lechner, C., Bartels, F., Finke, C., Breu, M., Flet‐Berliac, L., de Chalus, A., Adamsbaum, C., Capobianco, M. A. N., et al. (2020) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2020.10.005 · Cited by 160
Self-citationClinical and MRI phenotype of children with MOG antibodies
Fernandez-Carbonell, C., Vargas-Lowy, D., Musallam, A., Healy, B. C., McLaughlin, K., Wucherpfennig, K. W., & Chitnis, T. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515587751 · Cited by 151
Self-citationTreatment Approaches for MOG-Ab-Associated Demyelination in Children
Hacohen, Y., & Banwell, B. (2019) · Current Treatment Options in Neurology · doi:10.1007/s11940-019-0541-x · Cited by 150
Self-citationKothur, K., Wienholt, L. A., Mohammad, S. S., Tantsis, E. M., Pillai, S. C., Britton, P. N., Jones, C., Angiti, R. R., Barnes, E. H., Schlub, T. E., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161656 · Cited by 144
Self-citationWaldman, A. T., Ness, J., Pohl, D., Simone, I. L., Anlar, B., Amato, M. P., & Ghezzi, A. (2016) · Neurology · doi:10.1212/wnl.0000000000003028 · Cited by 136
Self-citationCole, J. J., Evans, E. M., Mwangi, M., & Mar, S. (2019) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2019.06.017 · Cited by 135
Clinical features of neuromyelitis optica in children
Chitnis, T., Ness, J., Krupp, L., Waubant, E. L., Hunt, T. D., Olsen, C. S., Rodriguez, M., Lotze, T., Gorman, M., Benson, L. A., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000002283 · Cited by 132
Self-citationSepúlveda, M., Armangué, T., Martínez‐Hernández, E., Arrambide, G., Solà‐Valls, N., Sabater, L., Téllez, N., Midaglia, L. S., Ariño, H., Peschl, P., et al. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8147-7 · Cited by 130
MOG antibody-related disorders: common features and uncommon presentations
Cobo‐Calvo, Á., Ruiz, A., d’Indy, H., Poulat, A., Carneiro, M., Nicolas, P., Durand‐Dubief, F., Deiva, K., Vukusic, S., Portes, V. D., et al. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8583-z · Cited by 130
Duignan, S. M., Wright, S. K., Rossor, T., Cazabon, J., Gilmour, K. C., Ciccarelli, O., Wassmer, E., Lim, M. J., Hemingway, C. A., & Hacohen, Y. (2018) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.13703 · Cited by 128
Self-citationChong, P. F., Kira, R., Mori, H., Okumura, A., Torisu, H., Yasumoto, S., Shimizu, H., Fujimoto, T., Hanaoka, N., Kusunoki, S., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix860 · Cited by 126
Multiple sclerosis: molecular pathogenesis and therapeutic intervention
Boutitah-Benyaich, I., Eixarch, H., Villacieros‐Álvarez, J., Hervera, A., Cobo‐Calvo, Á., Montalbán, X., & Espejo, C. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02415-4 · Cited by 149
Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19
Manzano, G. S., McEntire, C. R. S., Martinez‐Lage, M., Mateen, F. J., & Hutto, S. K. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001080 · Cited by 125
Acute disseminated encephalomyelitis in 228 patients
Koelman, D. L. H., Chahin, S., Mar, S., Venkatesan, A., Hoganson, G. M., Yeshokumar, A. K., Barreras, P., Majmudar-Sheth, B., Klein, J. P., Chitnis, T., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002723 · Cited by 124
Self-citationFerreira, M. L. B., de Albuquerque, M. D. F. P. M., de Brito, C. A. A., França, R. F. D. O., Moreira, Á. J. P., Machado, M. Í. D. M., Melo, R. D. P., Medialdea‐Carrera, R., Mesquita, S. D., Santos, M. L., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30232-5 · Cited by 123
Absoud, M., Greenberg, B. M., Lim, M. J., Lotze, T., Thomas, T. G. S., & Deiva, K. (2016) · Neurology · doi:10.1212/wnl.0000000000002820 · Cited by 122
Real‐World Effectiveness of Initial Disease‐Modifying Therapies in Pediatric Multiple Sclerosis
Krysko, K. M., Graves, J., Rensel, M. R., Weinstock‐Guttman, B., Rutatangwa, A., Aaen, G. S., Belman, A. L., Benson, L. A., Chitnis, T., Gorman, M., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25737 · Cited by 121
Self-citationFadda, G., Armangué, T., Hacohen, Y., Chitnis, T., & Banwell, B. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30432-4 · Cited by 118
Self-citationEvaluation of idiopathic transverse myelitis revealing specific myelopathy diagnoses
Zalewski, N. L., Flanagan, E. P., & Keegan, B. M. (2017) · Neurology · doi:10.1212/wnl.0000000000004796 · Cited by 112
Differential diagnosis of neuromyelitis optica spectrum disorders
Kim, S., Kim, S.-J., Lee, H. J., Kuroda, H., Palace, J. A., & Fujihara, K. (2017) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285617709723 · Cited by 114
Clinical and imaging features of children with autoimmune encephalitis and MOG antibodies
Wegener-Panzer, A., Cleaveland, R., Wendel, E., Baumann, M., Bertolini, A., Häusler, M., Knierim, E., Reiter‐Fink, E., Breu, M., Sönmez, Ö., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000731 · Cited by 108
Self-citationCharacterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination
the Australasian and New Zealand MOG Study Group, Tea, F., Lopez, J. A., Ramanathan, S., Merheb, V., Lee, F. X. Z., Zou, A., Pilli, D., Patrick, E., van der Walt, A., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0786-3 · Cited by 108
Self-citationPostacute Sequelae of SARS-CoV-2 in Children
Rao, S., Gross, R. S., Mohandas, S., Stein, C. R., Case, A., Dreyer, B. P., Pajor, N. M., Bunnell, H. T., Warburton, D., Berg, E. A., et al. (2024) · PEDIATRICS · doi:10.1542/peds.2023-062570 · Cited by 113
Kothur, K., Wienholt, L. A., Tantsis, E. M., Earl, J. W., Bandodkar, S., Prelog, K., Tea, F., Ramanathan, S., Brilot, F., & Dale, R. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149411 · Cited by 106
Self-citationMOG antibody–associated encephalomyelitis/encephalitis
Salama, S., Khan, M., Pardo, S., Izbudak, I., & Levy, M. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458519837705 · Cited by 100
Yamout, B., Sahraian, M. A., Bohlega, S., Aljumah, M., Gouider, R., Dahdaleh, M., Inshasi, J. S. S., Hashem, S., Alsharoqi, I., Khoury, S. J., et al. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.101459 · Cited by 107
Updates in NMOSD and MOGAD Diagnosis and Treatment
Cacciaguerra, L., & Flanagan, E. P. (2023) · Neurologic Clinics · doi:10.1016/j.ncl.2023.06.009 · Cited by 112
NMDA receptor antibodies associated with distinct white matter syndromes
Hacohen, Y., Absoud, M., Hemingway, C. A., Jacobson, L. W., Lin, J., Pike, M., Pullaperuma, S., Siddiqui, A. U., Wassmer, E., Waters, P. J., et al. (2014) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000002 · Cited by 99
Self-citationFitzgerald, K. C., Smith, M. D., Kim, S., Sotirchos, E. S., Kornberg, M. D., Douglas, M., Nourbakhsh, B., Graves, J., Rattan, R., Poisson, L., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100424 · Cited by 102
Pediatric CNS-isolated hemophagocytic lymphohistiocytosis
Benson, L. A., Li, H., Henderson, L. A., Solomon, I. H., Soldatos, A. G., Murphy, J. L., Bielekova, B., Kennedy, A. L., Rivkin, M. J., Davies, K. J., et al. (2019) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000560 · Cited by 98
Epidemiology of pediatric multiple sclerosis: A systematic literature review and meta-analysis
Yan, K., Balijepalli, C., Desai, K., Gullapalli, L., & Druyts, E. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102260 · Cited by 101
Contribution of dietary intake to relapse rate in early paediatric multiple sclerosis
Azary, S., Schreiner, T., Graves, J., Waldman, A. T., Belman, A. L., Guttman, B. W., Aaen, G. S., Tillema, J., Mar, S., Hart, J., et al. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-315936 · Cited by 101
Self-citationSiracusa, L., Cascio, A., Giordano, S. A., Medaglia, A. A., Restivo, G. A., Pirrone, I., Saia, G. F., Collura, F., & Colomba, C. (2021) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-021-01066-9 · Cited by 95
Improved relapse recovery in paediatric compared to adult multiple sclerosis
Chitnis, T., Aaen, G. S., Belman, A. L., Benson, L. A., Gorman, M., Goyal, M. S., Graves, J., Harris, Y., Krupp, L., Lotze, T. E., et al. (2020) · Brain · doi:10.1093/brain/awaa199 · Cited by 94
Self-citationAltered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course
Nourbakhsh, B., Bhargava, P., Tremlett, H. L., Hart, J., Graves, J., & Waubant, E. L. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.637 · Cited by 93
Baumann, M., Grams, A. E., Djurdjevic, T., Wendel, E., Lechner, C., Behring, B., Blaschek, A., Diepold, K., Eisenkölbl, A., Fluss, J., et al. (2018) · Journal of Neurology · doi:10.1007/s00415-018-8781-3 · Cited by 91
Self-citationCombined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment
Cortese, A., Franciotta, D. M., Alfonsi, E., Visigalli, N., Zardini, E., Diamanti, L., Prunetti, P., Osera, C., Gastaldi, M., Berzero, G., et al. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.02.022 · Cited by 92
Acute disseminated encephalomyelitis: current controversies in diagnosis and outcome
Koelman, D. L. H., & Mateen, F. J. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7694-7 · Cited by 89
Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination
Vogrig, A., Janes, F., Gigli, G. L., Curcio, F., Negro, I. D., D’Agostini, S., Fabris, M., & Valente, M. (2021) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2021.106839 · Cited by 88
Pediatric autoimmune encephalitis
de Bruijn, M. A. A. M., Bruijstens, A. L., Bastiaansen, A. E. M., van Sonderen, A., Schreurs, M. W. J., Smitt, P. A. E. S., Hintzen, R. Q., Neuteboom, R. F., & Titulaer, M. J. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000682 · Cited by 87
Self-citationUse of newer disease-modifying therapies in pediatric multiple sclerosis in the US
Krysko, K. M., Graves, J., Rensel, M. R., Weinstock‐Guttman, B., Aaen, G. S., Benson, L. A., Chitnis, T., Gorman, M., Goyal, M. S., Krupp, L., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000006471 · Cited by 83
Self-citationJarius, S., Lechner, C., Wendel, E. M., Baumann, M., Breu, M., Schimmel, M., Karenfort, M., Marina, A. D., Merkenschlager, A., Thiels, C., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01825-1 · Cited by 89
Self-citationLiguori, M., Nuzziello, N., Licciulli, F., Consiglio, A., Simone, M., Viterbo, R. G., Creanza, T. M., Ancona, N., Tortorella, C., Margari, L., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddx385 · Cited by 83
Fulminant demyelinating encephalomyelitis
Pauli, F. D., Höftberger, R., Reindl, M., Beer, R., Rhomberg, P., Schanda, K., Sato, D. K., Fujihara, K., Lassmann, H., Schmutzhard, E., et al. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000175 · Cited by 83
Acute Disseminated Encephalomyelitis: Current Perspectives
Paolilo, R. B., Deiva, K., Neuteboom, R. F., Rostasy, K. M., & Lim, M. J. (2020) · Children · doi:10.3390/children7110210 · Cited by 81
Self-citationChitnis, T., Banwell, B., Kappos, L., Arnold, D. L., Gücüyener, K., Deiva, K., Скрипченко, Н. В., Cui, L., Saubadu, S., Hu, W., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00364-1 · Cited by 81
Self-citationLower physical activity is associated with higher disease burden in pediatric multiple sclerosis
Grover, S. A., Aubert-Broche, B., Fetco, D., Collins, D. L., Arnold, D. L., Finlayson, M. L., Banwell, B., Motl, R. W., & Yeh, E. A. (2015) · Neurology · doi:10.1212/wnl.0000000000001939 · Cited by 86
Self-citationAntibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis
Nakajima, H., Motomura, M., Tanaka, K., Fujikawa, A., Nakata, R., Maeda, Y., Shima, T., Mukaino, A., Yoshimura, S., Miyazaki, T., et al. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-007766 · Cited by 78
Zuliani, L., Nosadini, M., Gastaldi, M., Spatola, M., Iorio, R., Zoccarato, M., Mariotto, S., Gaspari, P. D., Perini, F., Ferrari, S., et al. (2019) · Neurological Sciences · doi:10.1007/s10072-019-03930-3 · Cited by 79
Infectious and Autoimmune Causes of Encephalitis in Children
Erickson, T. A., Muscal, E., Muñoz, F. M., Lotze, T. E., Hasbun, R., Brown, E. L., & Murray, K. O. (2020) · PEDIATRICS · doi:10.1542/peds.2019-2543 · Cited by 77
Nosadini, M., Eyre, M., Giacomini, T., Valeriani, M., Corte, M. D., Praticò, A. D., Annovazzi, P. O. L., Cordani, R., Cordelli, D. M., Crichiutti, G., et al. (2022) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200065 · Cited by 79
MOG Spectrum Disorders and Role of MOG-Antibodies in Clinical Practice
Hennes, E.-M., Baumann, M., Lechner, C., & Rostasy, K. M. (2017) · Neuropediatrics · doi:10.1055/s-0037-1604404 · Cited by 76
Self-citationClinical trials of disease-modifying agents in pediatric MS
Waubant, E. L., Banwell, B., Wassmer, E., Sormani, M. P., Amato, M. P., Hintzen, R. Q., Krupp, L., Rostasy, K. M., Tenembaum, S. N., Chitnis, T., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007572 · Cited by 75
Self-citationConsensus definitions for pediatric MS and other demyelinating disorders in childhood
Tardieu, M., Banwell, B., Wolinsky, J. S., Pohl, D., & Krupp, L. (2016) · Neurology · doi:10.1212/wnl.0000000000002877 · Cited by 78
Self-citationAcute disseminated encephalomyelitis in a COVID-19 pediatric patient
Henriques‐Souza, A. M. D. M., de Melo, A. C. M. G., Madeiro, B. D. A. C. S., Freitas, L. F., Rocha‐Filho, P. A. S., & Gonçalves, F. G. (2020) · Neuroradiology · doi:10.1007/s00234-020-02571-0 · Cited by 74
Trewin, B. P., Brilot, F., Reddel, S., Dale, R. C., & Ramanathan, S. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103693 · Cited by 82
Self-citationTreatment and outcome of aquaporin-4 antibody–positive NMOSD
Paolilo, R. B., Hacohen, Y., Yazbeck, E., Armangué, T., Bruijstens, A. L., Lechner, C., Apóstolos‐Pereira, S. L., Martynenko, Y., Breu, M., Rimkus, C. D. M., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000837 · Cited by 72
Self-citationPediatric multiple sclerosis – current status of epidemiology, diagnosis and treatment
Brola, W., & Steinborn, B. (2020) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2020.0069 · Cited by 76
Metadata
- Authors
- Krupp, L. B., Tardieu, M., Amato, M. P., Banwell, B., Chitnis, T., Dale, R. C., Ghezzi, A., Hintzen, R., Kornberg, A., Pohl, D., Rostasy, K., Tenembaum, S., Wassmer, E., & for the International Pediatric Multiple Sclerosis Study Group
- Affiliations
- Stony Brook University Hospital (US)
- Hôpitaux universitaires Paris Sud (FR)
- University of Florence (IT)
- Children's Hospital of Philadelphia (US)
- Massachusetts General Hospital (US)
- The University of Sydney (AU)
- Centro Studi Sclerosi Multipl, Ospedale di Gallarate, Italy
- Erasmus MC (NL)
- Royal Children's Hospital (AU)
- Children's Hospital of Eastern Ontario (CA)
- Innsbruck Medical University (AT)
- Garrahan Hospital (AR)
- Birmingham Children's Hospital (GB)
- Corresponding author
- Krupp, Lauren B
- Tardieu, Marc
- ORCID
- Venue
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Published
- 2013-04-09
- Volume
- 19
- Issue
- 10
- Pages
- 1261-1267
- ISSN
- 1352-4585 (ISSN-L)
- 1477-0970
- OpenAlex
- W2025358672
- Cited by
- 1,130
- References
- 37
- Citations by year
- 2026: 57 · 2025: 74 · 2024: 95 · 2023: 111 · 2022: 102 · 2021: 106 · 2020: 99 · 2019: 100 · 2018: 98 · 2017: 93 · 2016: 80 · 2015: 60 · 2014: 42 · 2013: 10
- FWCI
- 47.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Multiple Sclerosis Journal (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Florence Research (University of Florence) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Keywords
- pediatric multiple sclerosis, diagnostic criteria, acute disseminated encephalomyelitis, neuromyelitis optica, clinical features, consensus definition
- MeSH terms
- Child, Encephalomyelitis, Acute Disseminated, Humans, Multiple Sclerosis, Neuromyelitis Optica, Pediatrics, Demyelinating Autoimmune Diseases, CNS
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
